JOSD1 and acute myeloid leukemia: JOSD1 was found to be up-regulated in the head and neck squamous cell carcinoma (HNSCC) (Jing et al., 2021), gynaecological cancer (GC) cells (Wu et al., 2020), and acute myeloid leukemia (AML) cells (Yang et al., 2022).